Robo.ai Initiates Revenue Recognition for Intelligent Data Business and Advances Tens of Thousands of Hours of Capacity Cooperation Across the Middle East and Asia

Robo.ai Initiates Revenue Recognition for Intelligent Data Business and Advances Tens of Thousands of Hours of Capacity Cooperation Across the Middle East and Asia

DUBAI, UAE, March 24, 2026 /PRNewswire/ -- Robo.ai Inc. (NASDAQ: AIIO) (the "Company" or "Robo.ai") today announced the capacity expansion plan for its intelligent data business segment. Following the delivery of its initial batch of real-world...

BioCina Initiates Comprehensive Manufacturing Program for Patrys' Proprietary Injectable Therapeutic to Alleviate Delirium

BioCina Initiates Comprehensive Manufacturing Program for Patrys' Proprietary Injectable Therapeutic to Alleviate Delirium

PERTH, Australia, March 17, 2026 /PRNewswire/ -- BioCina Pty Ltd., a global end-to-end Contract Development and Manufacturing Organisation (CDMO) announced it has initiated a comprehensive CMC (Chemistry, Manufacturing, and Controls) program for the...

Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial

Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial

Highlights: First participant enrolled and dosed with NUZ-001 in Regimen I of the HEALEY ALS Platform Trial evaluating NUZ-001 for the treatment of ALS Approximately 160 participants with ALS will be enrolled in a 36-week randomised, double-blind,...

SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family

SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family

Global phase 1/2 clinical trial initiated for GBP511, a vaccine targeting the Sarbecovirus Family Next-generation vaccine leveraging SKYCovione's recombinant protein-based platform and nanoparticle technology SK bioscience will continue to...

EPWK Curated Goods Officially Launches in January Next Year, Concurrently Initiates Global Supply Chain Recruitment Plan

EPWK Curated Goods Officially Launches in January Next Year, Concurrently Initiates Global Supply Chain Recruitment Plan

XIAMEN, China, Dec. 12, 2025 /PRNewswire/ -- Amidst the parallel trends of consumption upgrade and aesthetic evolution, the market calls for goods and shopping experiences that offer greater substance and stronger emotional connections. EPWK...

TEIZA Initiates The Malaysian Blockchain Consortium with 19 Strategic Partners Through Historic MOU Signing Ceremony

TEIZA Initiates The Malaysian Blockchain Consortium with 19 Strategic Partners Through Historic MOU Signing Ceremony

KUALA LUMPUR, Malaysia, Nov. 26, 2025 /PRNewswire/ -- TEIZA, a blockchain company invested in by the Finran Group, announced the formation of the Malaysia Blockchain Consortium, marking a pivotal milestone in the nation's digital transformation...

Pin Therapeutics Initiates First-Patient Dosing of CK1α Degrader PIN-5018 in Phase 1 Trial

Pin Therapeutics Initiates First-Patient Dosing of CK1α Degrader PIN-5018 in Phase 1 Trial

Preclinical Results Demonstrate Complete Response and Tumor Regression in ACC PDX Models SEOUL, South Korea, Nov. 24, 2025 /PRNewswire/ -- Pin Therapeutics, a clinical-stage biotechnology company specializing in targeted protein degradation,...

LISCure Biosciences Initiates Global Phase 2 Trial of LB-P8 in Primary Sclerosing Cholangitis (PSC)

LISCure Biosciences Initiates Global Phase 2 Trial of LB-P8 in Primary Sclerosing Cholangitis (PSC)

SEOUL, South Korea, Nov. 10, 2025 /PRNewswire/ -- LISCure Biosciences ("LISCure"), a clinical-stage biopharmaceutical company, announced the initiation of patient dosing in a global Phase 2 clinical trial of LB-P8, a novel therapeutic candidate for...

LEPAS Elegant Technology, Defined by You: LEPAS Fun Test Drive Interprets a New Paradigm for Intelligent Driving via User Co-Creation

LEPAS Elegant Technology, Defined by You: LEPAS Fun Test Drive Interprets a New Paradigm for Intelligent Driving via User Co-Creation

WUHU, China, Oct. 24, 2025 /PRNewswire/ -- From October 18 to 19, the LEPAS Fun Test Drive event successfully took place, following the Global Journey of Elegant Driving (China Stop) that concluded on October 15. Together, the two events showcased...

Clover Initiates Phase I Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates

Clover Initiates Phase I Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates

-- Potential First-in-Class Respiratory Combination Vaccine Candidates SCB-1022 (RSV + hMPV) and SCB-1033 (RSV + hMPV + PIV3) Enter the Clinical Trial Stage -- SHANGHAI, June 17, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX:...

  • 1
  • 2
  • menu
    menu